Treatment compliance at initial and maintenance therapy at gastroesophageal reflux disease

Aim of investigation. To analyze treatment compliance at initial course and maintenance treatment by proton pump inhibitors at gastroesophageal reflux disease (GERD). Material and methods. Overall 84 GERD patients with took part in prospective study: 50 (59.5%) men and 34 (40.5%) women aged from 18...

Full description

Saved in:
Bibliographic Details
Main Authors: V. I. Simanenkov, S. V. Tikhonov, N. B. Lischuk
Format: Article
Language:Russian
Published: Gastro LLC 2018-08-01
Series:Российский журнал гастроэнтерологии, гепатологии, колопроктологии
Subjects:
Online Access:https://www.gastro-j.ru/jour/article/view/120
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1823860276188938240
author V. I. Simanenkov
S. V. Tikhonov
N. B. Lischuk
author_facet V. I. Simanenkov
S. V. Tikhonov
N. B. Lischuk
author_sort V. I. Simanenkov
collection DOAJ
description Aim of investigation. To analyze treatment compliance at initial course and maintenance treatment by proton pump inhibitors at gastroesophageal reflux disease (GERD). Material and methods. Overall 84 GERD patients with took part in prospective study: 50 (59.5%) men and 34 (40.5%) women aged from 18 to 74 years. By results of esophagogastroduodenoscopy and morphological investigation of mucosal biopsies non-erosive reflux disease (NERD) was diagnosed in 32 (38.1%) patients, reflux esophagitis was found in 52 cases (61.9%). Total period of patients monitoring was 12 months at which patients made five visits to the research center: initial, through 1.5, 3, 6 and 12 months with filling in of questionnaires of Spielberger-Khanin, Beck, SF-36 and abridged multifactorial questionnaire of the personality (AMQP). Treatment compliance was established according to duration of study participation, along with that patients self-estimated it on 2, 3, 4 and 5 visits by Morisky-Green test and 5-score analog scales of pharmaceutical treatment compliance and lifestyle verification. The first visit patients underwent 1:1 randomization to the educational program devoted to reflux disease. Results. Of all patients 17.9% missed the second visit, the logistic regression analysis revealed no factors associated to the early low compliance; 38% of patients made all five visits for 12 months. The latter differed significantly from those who dropped out of the study at different stages: they had high number of chronic diseases (р
format Article
id doaj-art-49a7c701d71744828d9564d3a22bf39b
institution Kabale University
issn 1382-4376
2658-6673
language Russian
publishDate 2018-08-01
publisher Gastro LLC
record_format Article
series Российский журнал гастроэнтерологии, гепатологии, колопроктологии
spelling doaj-art-49a7c701d71744828d9564d3a22bf39b2025-02-10T16:14:28ZrusGastro LLCРоссийский журнал гастроэнтерологии, гепатологии, колопроктологии1382-43762658-66732018-08-01271293410.22416/1382-4376-2017-27-1-29-34120Treatment compliance at initial and maintenance therapy at gastroesophageal reflux diseaseV. I. Simanenkov0S. V. Tikhonov1N. B. Lischuk2Mechnikov North-Western State Medical UniversityMechnikov North-Western State Medical UniversityMechnikov North-Western State Medical UniversityAim of investigation. To analyze treatment compliance at initial course and maintenance treatment by proton pump inhibitors at gastroesophageal reflux disease (GERD). Material and methods. Overall 84 GERD patients with took part in prospective study: 50 (59.5%) men and 34 (40.5%) women aged from 18 to 74 years. By results of esophagogastroduodenoscopy and morphological investigation of mucosal biopsies non-erosive reflux disease (NERD) was diagnosed in 32 (38.1%) patients, reflux esophagitis was found in 52 cases (61.9%). Total period of patients monitoring was 12 months at which patients made five visits to the research center: initial, through 1.5, 3, 6 and 12 months with filling in of questionnaires of Spielberger-Khanin, Beck, SF-36 and abridged multifactorial questionnaire of the personality (AMQP). Treatment compliance was established according to duration of study participation, along with that patients self-estimated it on 2, 3, 4 and 5 visits by Morisky-Green test and 5-score analog scales of pharmaceutical treatment compliance and lifestyle verification. The first visit patients underwent 1:1 randomization to the educational program devoted to reflux disease. Results. Of all patients 17.9% missed the second visit, the logistic regression analysis revealed no factors associated to the early low compliance; 38% of patients made all five visits for 12 months. The latter differed significantly from those who dropped out of the study at different stages: they had high number of chronic diseases (рhttps://www.gastro-j.ru/jour/article/view/120гастроэзофагеальная рефлюксная болезньприверженность к лечениюингибиторы протонной помпыобразовательная программаподдерживающая терапия
spellingShingle V. I. Simanenkov
S. V. Tikhonov
N. B. Lischuk
Treatment compliance at initial and maintenance therapy at gastroesophageal reflux disease
Российский журнал гастроэнтерологии, гепатологии, колопроктологии
гастроэзофагеальная рефлюксная болезнь
приверженность к лечению
ингибиторы протонной помпы
образовательная программа
поддерживающая терапия
title Treatment compliance at initial and maintenance therapy at gastroesophageal reflux disease
title_full Treatment compliance at initial and maintenance therapy at gastroesophageal reflux disease
title_fullStr Treatment compliance at initial and maintenance therapy at gastroesophageal reflux disease
title_full_unstemmed Treatment compliance at initial and maintenance therapy at gastroesophageal reflux disease
title_short Treatment compliance at initial and maintenance therapy at gastroesophageal reflux disease
title_sort treatment compliance at initial and maintenance therapy at gastroesophageal reflux disease
topic гастроэзофагеальная рефлюксная болезнь
приверженность к лечению
ингибиторы протонной помпы
образовательная программа
поддерживающая терапия
url https://www.gastro-j.ru/jour/article/view/120
work_keys_str_mv AT visimanenkov treatmentcomplianceatinitialandmaintenancetherapyatgastroesophagealrefluxdisease
AT svtikhonov treatmentcomplianceatinitialandmaintenancetherapyatgastroesophagealrefluxdisease
AT nblischuk treatmentcomplianceatinitialandmaintenancetherapyatgastroesophagealrefluxdisease